ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms

被引：280

作者：

Delle Fave, Gianfranco ^{[1
]}

Kwekkeboom, Dik J. ^{[2
]}

Van Cutsem, Erik ^{[3
]}

Rindi, Guido ^{[4
]}

Kos-Kudla, Beata ^{[5
]}

Knigge, Ulrich ^{[6
]}

Sasano, Hironobu ^{[7
]}

Tomassetti, Paola ^{[8
]}

Salazar, Ramon ^{[9
]}

Ruszniewski, Philippe ^{[10
]}

机构：

[1] Univ Roma La Sapienza, St Andrea Hosp, Digest & Liver Dis Unit, Dept Digest & Liver Dis, IT-00189 Rome, Italy

[2] Royal Free Univ, UFR Bichat Beaujon Louis Mourier, Dept Oncol, Colombes, France

[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[4] Catholic Univ Policlin A Gemelli, Inst Pathol, Rome, Italy

[5] Med Univ Silesia, Dept Endocrinol, Katowice, Poland

[6] Copenhagen Univ Hosp, Rigshosp, Dept Surg, Copenhagen, Denmark

[7] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan

[8] Univ Bologna, St Orsola Hosp, Dept Internal Med & Gastroenterol, Bologna, Italy

[9] Inst Catala Oncol IDIBELL, Barcelona, Spain

[10] Beaujon Hosp, Dept Gastroenterol, Clichy, France

来源：

NEUROENDOCRINOLOGY | 2012年 / 95卷 / 02期

关键词：

ZOLLINGER-ELLISON-SYNDROME; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; DUODENAL CARCINOID-TUMOR; ENDOCRINE GASTROENTEROPANCREATIC TUMORS; ATROPHIC BODY GASTRITIS; NEUROENDOCRINE TUMORS; BONE METASTASES; ENDOSCOPIC ULTRASONOGRAPHY; GANGLIOCYTIC PARAGANGLIOMA; CLINICAL CHARACTERISTICS;

D O I：

10.1159/000335595

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：74 / 87

页数：14

共 145 条

[1]

Acs G, 2000, DIAGN CYTOPATHOL, V23, P183, DOI 10.1002/1097-0339(200009)23:3<183::AID-DC8>3.0.CO

[2]

2-4

[3] Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zolinger-Ellison syndrome [J].

Alexander, HR ;

Fraker, DL ;

Norton, JA ;

Bartlett, DL ;

Tio, L ;

Benjamin, SB ;

Doppman, JL ;

Goebel, SU ;

Serrano, J ;

Gibril, F ;

Jensen, RT .

ANNALS OF SURGERY, 1998, 228 (02) :228-238

[4] Duodenal periampullary gangliocytic paraganglioma: Report of two cases with immunohistochemical and ultrastructural study [J].

Altavilla, G ;

Chiarelli, S ;

Fassina, A .

ULTRASTRUCTURAL PATHOLOGY, 2001, 25 (02) :137-145

[5] NEURO-HORMONAL PEPTIDES IN ENDOCRINE TUMORS OF THE PANCREAS, STOMACH, AND UPPER SMALL-INTESTINE .1. AN IMMUNOHISTOCHEMICAL STUDY OF 27 CASES [J].

ALUMETS, J ;

SUNDLER, F ;

FALKMER, S ;

LJUNGBERG, O ;

HAKANSON, R ;

MARTENSSON, H ;

NOBIN, A ;

LASSON, A .

ULTRASTRUCTURAL PATHOLOGY, 1983, 5 (01) :55-72

[6]

AMANO S, 1978, ACTA PATHOL JAPON, V28, P721

[7] Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid [J].

Annibale, B ;

Azzoni, C ;

Corleto, VD ;

di Giulio, E ;

Caruana, P ;

D'ambra, G ;

Bordi, C ;

Delle Fave, G .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (12) :1449-1456

[8]

[Anonymous], 2010, WHO CLASSIFICATION T

[9] Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors:: A randomized trial [J].

Arnold, R ;

Rinke, A ;

Klose, KJ ;

Müller, HH ;

Wied, M ;

Zamzow, K ;

Schmidt, C ;

Schade-Brittinger, C ;

Barth, P ;

Moll, R ;

Koller, M ;

Unterhalt, M ;

Hiddemann, W ;

Schmidt-Lauber, M ;

Pavel, M ;

Arnold, CN .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (08) :761-771

[10]

ATTANOOS R, 1991, SEMIN DIAGN PATHOL, V8, P149

← 1 2 3 4 5 6 7 8 9 10 →